Clinical trial
Sandostatin for Patients With Androgen Independent Prostate Cancer
NCT00510224
Study timeline
Study start (unknown)2007-07-01Date precision: month
Registry last updated2013-12-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
SandostatinDRUG · verified · RxNorm: Sandostatin
Sponsors & collaborators
University of California, San Franciscolead sponsor
Novartiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00510224 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.